TG Therapeutics, Inc. (TGTX)
$55.37+3.81%Close
SELLBEAR · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8.5B
- Beta
- 1.66
- P/E (TTM)
- 17.14
- Short % float
- 22.68%
- Days to cover
- 15.0
- SI change
- +1.6%
- 1W
- +1.99%
- 1M
- -0.04%
- vs SPY 1W
- +0.83%
- vs SPY 1M
- -3.03%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on TGTX?
- LOPJLB’s latest quantitative signal on TG Therapeutics, Inc. (TGTX) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is TGTX in?
- TG Therapeutics, Inc. (TGTX) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does TG Therapeutics, Inc. (TGTX) do?
- Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and various autoimmune disorders. Among its significant inv…